Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overactive Bladder(OAB)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07540273
What this trial is testing

Effectiveness of Ambulatory Transcutaneous Tibial Nerve Stimulation for Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)Urinary Urgency
SEZGIN 60
Post-approval studies (Phase 4)Study completedNCT00806494
What this trial is testing

UK Study Assessing Flexible Dose Fesoterodine in Adults

Who this might be right for
Urinary Bladder, Overactive
Pfizer 331
Post-approval studies (Phase 4)Study completedNCT00922506
What this trial is testing

Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

Who this might be right for
Overactive BladderBenign Prostatic Hyperplasia
Samsung Medical Center 83
Not applicableActive Not RecruitingNCT07554989
What this trial is testing

Comparison of Concurrent Endoscopic Prostate Surgery With Botox-A Injection and Postoperative Medical Therapy in BPH Patients With Overactive Bladder Symptoms

Who this might be right for
Urinary Bladder, OveractiveProstatic Hyperplasia, BenignBladder Outlet Obstruction+1 more
Taksim Egitim ve Arastirma Hastanesi 70
Post-approval studies (Phase 4)Study completedNCT02216214
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

Who this might be right for
Overactive Bladder (OAB)
Astellas Pharma Global Development, Inc. 888
Not applicableStudy completedNCT05211193
What this trial is testing

Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

Who this might be right for
Overactive Bladder (OAB)Failed Any OAB Pharmacotherapy
Stimvia s.r.o. 40
Not applicableLooking for participantsNCT07335484
What this trial is testing

Aquarius Pilot Study to Evaluate the New Axonics Trial System

Who this might be right for
Urinary Urge Incontinence (UUI)Urinary Frequency (UF)Fecal Incontinence (FI)+1 more
Axonics, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT03475706
What this trial is testing

Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women

Who this might be right for
Overactive Bladder
Velicept Therapeutics, Inc. 438
Not applicableStudy completedNCT02107820
What this trial is testing

Does Bladder Training Improve the Efficacy of Nerve Stimulation in Women With Refractory Overactive Bladders

Who this might be right for
Overactive Bladder
University Hospital Plymouth NHS Trust 84
Post-approval studies (Phase 4)Study completedNCT04562090
What this trial is testing

A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder

Who this might be right for
Urge IncontinenceOveractive Bladder (OAB)
Astellas Pharma China, Inc. 249
Not applicableStudy completedNCT06785558
What this trial is testing

The Role of Urinary ATP in the Diagnosis, Treatment, and Follow-up of Children With Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)
Marmara University 40
Post-approval studies (Phase 4)Study completedNCT00127270
What this trial is testing

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

Who this might be right for
Urinary Incontinence
Novartis 395
Not applicableNot Yet RecruitingNCT07279142
What this trial is testing

Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)Incontinence, Urge
IRCCS San Raffaele 48
Large-scale testing (Phase 3)Study completedNCT01655069
What this trial is testing

Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Europe B.V. 148
Not applicableLooking for participantsNCT06659536
What this trial is testing

Cefar URO - Symptomatic Treatment of Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)Refractory Overactive BladderUrinary Urgency and Frequency
DJO UK Ltd 53
Large-scale testing (Phase 3)Study completedNCT00662909
What this trial is testing

Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 2,149
Post-approval studies (Phase 4)Study completedNCT06780163
What this trial is testing

Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)MenopauseMicrobiome
Mahidol University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07553065
What this trial is testing

RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)
Vensica Therapeutics Ltd. 210
Post-approval studies (Phase 4)Study completedNCT00645281
What this trial is testing

Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

Who this might be right for
Urinary Bladder, Overactive
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 896
Early research (Phase 1)Study completedNCT02211846
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder

Who this might be right for
Neurogenic Detrusor OveractivityOveractive BladderPharmacokinetics of Mirabegron
Astellas Pharma Inc 34
Next Page